To assess the PCa tumour microenvironment for impaired immunity, we also performed a pilot RNA-expression analysis for PCa-associated immunological factors (IL1β, IL10, IL18, TNF-α, TLR4, GATA3, CD68). The gene discussed is IL10; the disease is neoplasm.